Literature DB >> 21517902

Allergic bronchopulmonary aspergillosis and omalizumab.

I Tillie-Leblond1, P Germaud, C Leroyer, L Tétu, F Girard, G Devouassoux, J-P Grignet, A Prudhomme, D Dusser, B Wallaert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21517902     DOI： 10.1111/j.1398-9995.2011.02599.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  13 in total

Review 1.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

2.  Exophiala pisciphila: a novel cause of allergic bronchopulmonary mycosis.

Authors:  Jad Kebbe; M Jeffery Mador
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  A rare CFTR intronic mutation related to a mild CF disease in a 12-year-old girl.

Authors:  Nadia Nathan; Emmanuelle Girodon; Annick Clement; Harriet Corvol
Journal:  BMJ Case Rep       Date:  2012-11-09

Review 4.  Allergic bronchopulmonary aspergillosis.

Authors:  Paul A Greenberger; Robert K Bush; Jeffrey G Demain; Amber Luong; Raymond G Slavin; Alan P Knutsen
Journal:  J Allergy Clin Immunol Pract       Date:  2014-11-06

5.  Allergic Bronchopulmonary Aspergillosis with an Atypical Mass-Like Presentation.

Authors:  Mahmoud Ibrahim Mahmoud; Alaeldin Elfaki; Ziad A Alhaj; Abir Hamad Said
Journal:  Case Rep Pulmonol       Date:  2022-06-13

Review 6.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 7.  Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Authors:  Ibrahim Ahmed Janahi; Abdul Rehman; Amal Rashid Al-Naimi
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

8.  Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab.

Authors:  Jennifer Collins; Gabriele Devos; Golda Hudes; David Rosenstreich
Journal:  J Asthma Allergy       Date:  2012-11-08

9.  Steroid sparing effect of omalizumab in seropositive allergic bronchopulmonary aspergillosis.

Authors:  Keith T Beam; Christopher A Coop
Journal:  Allergy Rhinol (Providence)       Date:  2015-01

Review 10.  Allergic Bronchopulmonary Aspergillosis: A Perplexing Clinical Entity.

Authors:  Ashok Shah; Chandramani Panjabi
Journal:  Allergy Asthma Immunol Res       Date:  2016-07       Impact factor: 5.764
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.